Everslim Weight Loss Guides
BMI Criteria for Weight Loss Medication UK: What You Need to Qualify
A clear guide to the BMI thresholds used across Mounjaro, Wegovy and Orlistat in the UK, including comorbidity rules, ethnicity-adjusted thresholds, and how a GPhC-registered prescriber assesses your eligibility.
Quick Answer
In the UK, prescription weight loss injections such as Mounjaro and Wegovy are generally offered to adults with a BMI of 30 or above, or a BMI of 27 to 30 alongside a weight-related health condition such as type 2 diabetes, high blood pressure or high cholesterol. Orlistat has a lower threshold, typically from a BMI of 28. These figures are a starting point, not a guarantee. A UK-registered prescriber reviews your full medical history before any medication is approved.
In This Guide
What BMI Criteria for Weight Loss Medication Actually Means
Body Mass Index, or BMI, is a simple calculation of weight relative to height. It’s not a perfect measure of health, and it doesn’t account for muscle mass, fat distribution, or individual medical circumstances. However, UK prescribers use BMI as one of several starting checkpoints when assessing whether a prescription weight loss medicine is likely to be appropriate and proportionate for a patient.
Medicines such as Mounjaro (tirzepatide) and Wegovy (semaglutide) belong to a class of medicines called GLP-1 receptor agonists (Mounjaro also acts on GIP receptors). They carry real clinical benefits for people living with obesity, but they also carry real risks and side effects, so regulators and prescribers use BMI thresholds to help identify who is most likely to benefit safely. This is why a private prescriber will always ask for your height and weight, alongside your medical history, before recommending any treatment.
Find out how much weight you may lose on weight loss medication based on your current weight and height, or read on to learn more about treatment, suitability, and more.
When Treatment May Be Suitable
The BMI ranges below reflect the general criteria used across UK weight management pathways, including Everslim’s own clinical assessment process. They are guidance, not a diagnosis, and every application is reviewed individually by a UK-licensed prescriber.
BMI 30 and above
Generally meets the threshold for GLP-1 injectable treatments such as Mounjaro and Wegovy, subject to full clinical review.
BMI 27 to 30
May still be eligible if you have a weight-related condition such as type 2 diabetes, hypertension or high cholesterol.
BMI 28 and above
The typical minimum threshold considered for Orlistat, a non-injectable option.
It’s also worth knowing that clinical guidance recognises higher health risks at lower BMI for some ethnic groups, including people of South Asian, Chinese, Black African and African-Caribbean heritage. Where relevant, a prescriber may take this into account and apply an adjusted threshold as part of a holistic assessment, rather than relying on a single BMI number in isolation.
Age eligibility across Everslim’s weight loss range is generally 18 to 74. Treatment is not suitable during pregnancy or while breastfeeding, and your prescriber will ask about this directly during your consultation.

Available Treatment Options
Everslim offers a small, clinically-led range of weight management treatments rather than a long list of products. Each is prescription-only and reviewed by a UK-licensed prescriber before dispensing by Everest Pharmacy Hub, a GPhC and NHS-registered pharmacy.
- Mounjaro (tirzepatide) — weekly injection, from £149.99 per month including prescription
- Wegovy (semaglutide) injection — weekly injection, from £99.99 per month including prescription
- Wegovy Pill (semaglutide) — daily oral tablet, from £99.99 per month including prescription
- Orlistat capsules — taken three times daily with meals, from £39.99 per month including prescription
Prices shown are starting prices correct at time of writing and are confirmed at checkout following your consultation. For a full breakdown of how these medicines work, read Everslim’s complete medical guide to weight loss injections.
BMI Threshold Comparison Table
| Treatment | Typical BMI Threshold | Administration | From (per month) |
|---|---|---|---|
| Mounjaro | 30+, or 27-30 with a comorbidity | Weekly injection | £149.99 |
| Wegovy (injection) | 30+, or 27-30 with a comorbidity | Weekly injection | £99.99 |
| Wegovy Pill | 30+, or 27-30 with a comorbidity | Daily tablet | £99.99 |
| Orlistat | 28+ | Capsule, three times daily | £39.99 |
Figures are general guidance only. Final eligibility is decided by your prescriber following a full clinical assessment, not by BMI alone.
Safety and Suitability
Meeting a BMI threshold does not automatically mean a medicine is right for you, and no prescriber should ever suggest otherwise. During your consultation, a UK-licensed prescriber will also consider your full medical history, current medications, any personal or family history of thyroid or pancreatic conditions, eating disorder history, and whether you’re pregnant, breastfeeding, or planning a pregnancy. GLP-1 medicines are not suitable for everyone, and your prescriber may decline to prescribe, or recommend an alternative such as Orlistat, if injectable treatment isn’t appropriate for your circumstances.
Important: Prescription weight loss medication should never be sourced without a genuine clinical assessment. If a website offers these medicines without asking detailed questions about your health, that is a red flag, not a shortcut.
Side Effects and When to Seek Help
The most commonly reported side effects of GLP-1 treatments include nausea, constipation, diarrhoea and fatigue, particularly in the first few weeks or after a dose increase. These are usually mild and tend to settle as your body adjusts. Orlistat’s side effects relate mainly to fat digestion, including oily stools and changes in bowel habits, which are usually managed by following the recommended lower-fat diet.
Seek urgent medical help if you experience severe or persistent abdominal pain, signs of a severe allergic reaction, yellowing of the skin or eyes, or symptoms of pancreatitis such as intense pain that spreads to your back. These are rare but serious, and you should contact NHS 111, your GP, or A&E in an emergency rather than waiting for a routine follow-up.
Buying Safely Online in the UK
Weight loss injections have become a target for counterfeit products sold outside regulated channels. Before buying online, check that the provider is linked to a pharmacy registered with the General Pharmaceutical Council (GPhC), that a genuine clinical consultation is required before any prescription is issued, and that pricing is transparent with no obligation if you’re not eligible. Our guide on GPhC and pharmacy regulation explains what to check before you buy.

Why Choose Everslim
Everslim is powered by Everest Pharmacy Hub, a GPhC-registered pharmacy (GPhC No. 9012643) that has operated across the UK since 2008. Every order is reviewed individually by a UK-licensed independent prescriber, pricing is shown upfront with no hidden fees, and you’re only charged if your prescription is approved. Support doesn’t stop at checkout: patients have access to ongoing clinical review and a dedicated health coach throughout their treatment.
FAQs
What BMI do I need for Mounjaro or Wegovy in the UK?
Generally a BMI of 30 or above, or 27 to 30 with a weight-related health condition such as type 2 diabetes or high blood pressure. Your prescriber confirms this alongside a full health review.
Can I get weight loss medication with a BMI under 30?
Possibly, if your BMI is between 27 and 30 and you have a relevant weight-related condition. Read our detailed guide on Mounjaro eligibility with a BMI under 30 for more detail.
Is Orlistat easier to qualify for than Mounjaro or Wegovy?
The typical BMI threshold for Orlistat is lower, from around 28, but suitability still depends on a full clinical assessment, not BMI alone.
Does my ethnicity affect the BMI threshold used?
It can. Some ethnic groups face higher weight-related health risks at lower BMI, and a prescriber may take this into account as part of a wider assessment.
Can I get weight loss medication on the NHS instead?
Some NHS specialist weight management services now offer Wegovy and Mounjaro, but access is limited and waiting times can be long. Read more in our Mounjaro NHS eligibility guide.
What happens if my BMI doesn’t meet the criteria?
You won’t be charged and won’t be prescribed medication that isn’t clinically appropriate. Your prescriber may suggest an alternative treatment, refer you to your GP, or recommend lifestyle-based support through Everslim’s health coaching instead.
Do I need to submit proof of my height and weight?
You’ll self-report these during your online consultation. It’s important to answer accurately, as your prescriber relies on this information, alongside your wider medical history, to assess whether treatment is safe and suitable for you.
Will my BMI affect which starting dose I’m prescribed?
BMI is one factor your prescriber considers alongside your health history when deciding a starting dose. Treatment typically begins at a low dose and is only increased gradually if it’s well tolerated, regardless of BMI.
Find Out If You’re Eligible
Complete a free, confidential consultation and a UK-registered prescriber will confirm which treatment, if any, is suitable for you.
Medical disclaimer: This article is for general information only and does not constitute medical advice. It is not a substitute for a consultation with a qualified healthcare professional. Prescription weight loss medications require a full clinical assessment and are not suitable for everyone. Individual results vary. If you experience severe side effects or symptoms that concern you, seek medical attention promptly, including from NHS 111 or your GP.



